loadpatents
Patent applications and USPTO patent grants for Cottam; Howard B..The latest application filed is for "n-aryl sulfonamide derivatives as vaccine adjuvant".
Patent | Date |
---|---|
N-aryl Sulfonamide Derivatives As Vaccine Adjuvant App 20220305121 - Carson; Dennis A. ;   et al. | 2022-09-29 |
Tlr4-tlr7 Ligand Formulations As Vaccine Adjuvants App 20220152188 - Carson; Dennis A. ;   et al. | 2022-05-19 |
Vaccine Adjuvant App 20210380546 - Carson; Dennis ;   et al. | 2021-12-09 |
Compositions and methods for modulating TLR4 Grant 9,505,768 - Carson , et al. November 29, 2 | 2016-11-29 |
Uses Of Phospholipid Conjugates Of Synthetic Tlr7 Agonists App 20160199499 - Carson; Dennis A. ;   et al. | 2016-07-14 |
TLR agonists Grant 9,359,360 - Carson , et al. June 7, 2 | 2016-06-07 |
Synthetic Tlr4 And Tlr7 Ligands As Vaccine Adjuvants App 20150366962 - Carson; Dennis A. ;   et al. | 2015-12-24 |
Compositions And Methods For Modulating Tlr4 App 20150197527 - Carson; Dennis A. ;   et al. | 2015-07-16 |
Conjugates of synthetic TLR agonists and uses therefor Grant 9,050,376 - Carson , et al. June 9, 2 | 2015-06-09 |
Novel Immune Activators: Substitute 4-aminoquinazolines App 20150132342 - Carson; Dennis A. ;   et al. | 2015-05-14 |
Conjugates Of Synthetic Tlr Agonists And Uses Therefor App 20140302120 - Carson; Dennis A. ;   et al. | 2014-10-09 |
Purine analogs Grant 8,846,697 - Carson , et al. September 30, 2 | 2014-09-30 |
Conjugates of synthetic TLR agonists and uses therefor Grant 8,790,655 - Carson , et al. July 29, 2 | 2014-07-29 |
Toll-like receptor modulators and treatment of diseases Grant 8,729,088 - Carson , et al. May 20, 2 | 2014-05-20 |
Uses Of Phospholipid Conjugates Of Synthetic Tlr7 Agonists App 20130202629 - Carson; Dennis A. ;   et al. | 2013-08-08 |
Purine Analogs App 20130190494 - Carson; Dennis A. ;   et al. | 2013-07-25 |
Tlr Agonists App 20130165455 - Carson; Dennis A. ;   et al. | 2013-06-27 |
Conjugates Of Synthetic Tlr Agonists And Uses Therefor App 20130156807 - Carson; Dennis A. ;   et al. | 2013-06-20 |
Conjugates Of Synthetic Tlr Agonists And Uses Therefor App 20120148660 - Carson; Dennis A. ;   et al. | 2012-06-14 |
Derivatives of hypoestoxide and related compounds Grant 8,124,654 - Cottam , et al. February 28, 2 | 2012-02-28 |
Amide Derivatives Of Ethacrynic Acid App 20110306671 - Carson; Dennis A. ;   et al. | 2011-12-15 |
Purine Analogs App 20110098294 - Carson; Dennis A. ;   et al. | 2011-04-28 |
Apoptosis inhibitors Grant 7,816,352 - Carson , et al. October 19, 2 | 2010-10-19 |
Toll-like Receptor Modulators And Treatment Of Diseases App 20100210598 - Carson; Dennis A. ;   et al. | 2010-08-19 |
Derivatives of Hypoestoxide and Related Compounds App 20100120853 - Cottam; Howard B. ;   et al. | 2010-05-13 |
Tlr Agonists App 20090324551 - Carson; Dennis A. ;   et al. | 2009-12-31 |
Compounds having activity as inhibitors of apoptosis Grant 7,601,846 - Cottam , et al. October 13, 2 | 2009-10-13 |
Apoptosis Inhibitors App 20080280903 - Carson; Dennis A. ;   et al. | 2008-11-13 |
Indole compounds useful for the treatment of cancer Grant 7,361,680 - Carson , et al. April 22, 2 | 2008-04-22 |
Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents Grant 7,229,979 - Nchekwube , et al. June 12, 2 | 2007-06-12 |
Indole Compounds Useful For The Treatment Of Cancer App 20070111950 - Carson; Dennis A. ;   et al. | 2007-05-17 |
Use of etodolac for the treatment of chronic lymphocytic leukemia Grant 7,189,752 - Carson , et al. March 13, 2 | 2007-03-13 |
Indole Compounds Useful For The Treatment Of Cancer App 20060293253 - Carson; Dennis A. ;   et al. | 2006-12-28 |
Indole compounds useful for the treatment of cancer Grant 7,151,100 - Carson , et al. December 19, 2 | 2006-12-19 |
Indole compounds useful for the treatment of cancer Grant 7,129,262 - Carson , et al. October 31, 2 | 2006-10-31 |
Use of etodolac in the treatment of multiple myeloma Grant 7,105,560 - Carson , et al. September 12, 2 | 2006-09-12 |
Use of etodolac for the treatment of prostate cancer Grant 7,105,561 - Carson , et al. September 12, 2 | 2006-09-12 |
Thiazolopyrimidines useful as TNF.alpha. inhibitors Grant 7,098,216 - Carson , et al. August 29, 2 | 2006-08-29 |
Compounds having activity as inhibitors of apoptosis App 20060122178 - Cottam; Howard B. ;   et al. | 2006-06-08 |
Use of STAT-6 inhibitors as therapeutic agents App 20060040934 - Cottam; Howard B. ;   et al. | 2006-02-23 |
Indole compounds useful for the treatment of cancer App 20050239752 - Carson, Dennis A. ;   et al. | 2005-10-27 |
Thiazolopyrimidines useful as TNF.alpha. inhibitors Grant 6,930,101 - Carson , et al. August 16, 2 | 2005-08-16 |
Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs App 20050154010 - Carson, Dennis A ;   et al. | 2005-07-14 |
Hypoestoxides, derivatives, agonists and crude extracts thereof for use in cosmetic compositions App 20050112071 - Ojo-Amaize, Emmanuel A. ;   et al. | 2005-05-26 |
Thiazolopyrimidines useful as TNFalpha inhibitors App 20050065116 - Carson, Dennis A. ;   et al. | 2005-03-24 |
Combined use of IMPDH inhibitors with toll-like receptor agonists App 20050004144 - Carson, Dennis A. ;   et al. | 2005-01-06 |
Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents App 20040258728 - Nchekwube, Emeka J. ;   et al. | 2004-12-23 |
Indole compounds useful for the treatment of cancer App 20040152672 - Carson, Dennis A. ;   et al. | 2004-08-05 |
Use of etodolac for the treatment of chronic lymphocytic leukemia App 20040147582 - Carson, Dennis A. ;   et al. | 2004-07-29 |
Uses for inhibitors of inosine monophosphate dehydrogenase App 20040127435 - Carson, Dennis A. ;   et al. | 2004-07-01 |
Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemia App 20040087553 - Nchekwube, Emeka J. ;   et al. | 2004-05-06 |
Inhibition of p53-induced stress response Grant 6,696,441 - Cottam , et al. February 24, 2 | 2004-02-24 |
Use of STAT-6 inhibitors as therapeutic agents App 20030232794 - Cottam, Howard B. ;   et al. | 2003-12-18 |
Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogs App 20030216426 - Carson, Dennis A. ;   et al. | 2003-11-20 |
Use of STAT-6 inhibitors as therapeutic agents App 20030143199 - Carson, Dennis A. ;   et al. | 2003-07-31 |
Use of etodolac for the treatment of chronic lymphocytic leukemia App 20030078293 - Carson, Dennis A. ;   et al. | 2003-04-24 |
Use of etodolac for the treatment of chronic lymphocytic leukemia Grant 6,545,034 - Carson , et al. April 8, 2 | 2003-04-08 |
Assay for agents that induce chemokinesis App 20020010125 - Carson, Dennis A. ;   et al. | 2002-01-24 |
Compounds for inhibition of ceramide-mediated signal transduction Grant 5,843,943 - Carson , et al. December 1, 1 | 1998-12-01 |
Compositions and methods for immunosuppressing Grant 5,801,193 - Ojo-Amaize , et al. September 1, 1 | 1998-09-01 |
Immunosuppression by administration of N.sup.6,N.sup.6 -disubstituted cAMP's, analogues thereof, and related nucleosides Grant 5,747,474 - Ojo-Amaize , et al. May 5, 1 | 1998-05-05 |
Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives Grant 4,880,784 - Robins , et al. November 14, 1 | 1989-11-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.